News and Events


Laura Palombi

After seeing her rural Minnesota community struggle with a growing heroin and opioid addiction problem, Assistant Professor Laura Palombi set out to do something about it.

Palombi – working alongside a grassroots, drug abuse-focused task force – sought to hold a forum that would bring together members of the Cloquet, Minn. community to find a solution.

Carolyn Fairbanks

Keeping painkilling drugs out of the brain would prevent drug addiction. Carolyn Fairbanks seeks that goal, as well as ways to stop pain impulses before they reach the brain.

award trophy

Congratulations to our faculty and alumni who received Minnesota Pharmacists Association 2016 awards at this past weekend's MPhA Annual Learning Networking Event.

stack of books

The University of Minnesota College of Pharmacy is pleased to announce the selection of William Elmquist and Pamala Jacobson as Distinguished Professors under the Pharmacy Scholars program.

Michelle Aytay

Michelle Aytay, a 1996 graduate of the College of Pharmacy, has been selected to receive the University of Minnesota Alumni Service Award. The award recognizes her service as a volunteer who has had a major impact on the University. U of M President Eric Kaler will confer the award at the Oct. 20 Alumni Awards Dinner.

DNA strands

Imagine if an individual’s DNA could be matched to the most effective medication to treat his or her case specifically. Using pharmacogenomics, researchers and providers are getting closer to achieving this goal.

Shannon Reidt

Managing medications can be difficult. An aging population with a variety of health challenges brings the need for more at-home care options, especially for managing medications.

Healthcare team

Did you know that your pharmacist is more than someone who fills prescriptions?

Dr. Mark Schneiderhan

Pharmacists can help keep tabs on the overall health of those with mental illnesses.

Gunda Georg

What does it take to get to that moment in a clinic when a doctor gives a patient a compound never before used in modern medicine? The story of Minnelide, an investigational drug for pancreatic cancer patients now in a Phase IA clinical trial at the University of Minnesota, illustrates just how complex and exhilarating that journey can be.